JW Pharmaceutical Corporation acquired Euvipharm Pharmaceutical Joint-Stock Company.
JW Pharmaceutical Corporation (KOSE:A001060) acquired Euvipharm Pharmaceutical Joint-Stock Company on September 4, 2019. Korea Trade-Investment Promotion Agency's M&A investment team and Ho Chi Minh Office provided support to JW Pharmaceutical throughout the contract-signing process.
JW Pharmaceutical Corporation (KOSE:A001060) completed the acquisition of Euvipharm Pharmaceutical Joint-Stock Company on September 4, 2019.